Medexus Pharmaceuticals Inc.
MEDXF
$3.50
-$0.05-1.46%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -72.79% | 77.41% | 34.53% | 10.39% | 356.19% |
| Total Receivables | 11.66% | -16.31% | -7.45% | -6.69% | -44.63% |
| Inventory | -7.41% | -7.96% | -10.30% | -2.38% | 8.44% |
| Prepaid Expenses | 64.26% | 21.46% | 19.91% | 0.34% | -26.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 18.88% | -- | -- | -- | -83.66% |
| Total Current Assets | -20.84% | 4.87% | -2.75% | -1.89% | 11.14% |
|
|
|||||
| Total Current Assets | -20.84% | 4.87% | -2.75% | -1.89% | 11.14% |
| Net Property, Plant & Equipment | -38.75% | -35.81% | -30.64% | -23.29% | -11.44% |
| Long-term Investments | 1.44% | 2.28% | -1.44% | 0.16% | -2.72% |
| Goodwill | 1.44% | 2.28% | -1.44% | 0.16% | -2.72% |
| Total Other Intangibles | -12.94% | 9.25% | 9.35% | 10.84% | 11.63% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.03% | 3.22% | 5.45% | 13.87% | 11.65% |
| Total Assets | -14.29% | 6.17% | 2.80% | 4.43% | 10.34% |
|
|
|||||
| Total Accounts Payable | 43.49% | 9.13% | 1.54% | 11.99% | -26.06% |
| Total Accrued Expenses | 8.21% | -- | -- | -- | -0.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -94.02% | -59.45% | 17.96% | 31.16% | 134.90% |
| Total Finance Division Other Current Liabilities | -74.87% | 33.54% | 90.27% | 141.76% | 164.42% |
| Total Other Current Liabilities | -74.87% | 33.54% | 90.27% | 141.76% | 164.42% |
| Total Current Liabilities | -44.94% | -5.95% | 18.12% | 33.18% | 46.93% |
|
|
|||||
| Total Current Liabilities | -44.94% | -5.95% | 18.12% | 33.18% | 46.93% |
| Long-Term Debt | -- | -16.83% | -100.41% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 32.32% | -82.33% | -54.18% | -67.88% | -63.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.15% | -8.80% | -8.36% | -13.49% | -11.35% |
| Total Liabilities | -17.88% | -8.95% | -13.85% | -12.07% | -4.56% |
|
|
|||||
| Common Stock & APIC | -0.77% | 21.52% | 21.96% | 21.99% | 22.30% |
| Retained Earnings | -3.86% | -0.44% | 0.61% | 1.29% | 3.50% |
| Treasury Stock & Other | 1.21% | 5.11% | -2.81% | 0.80% | -2.29% |
| Total Common Equity | -6.05% | 57.73% | 60.10% | 62.52% | 71.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.05% | 57.73% | 60.10% | 62.52% | 71.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.05% | 57.73% | 60.10% | 62.52% | 71.96% |
|
|
|||||